Periphery Exploration around 2,6-Diazaspiro[3.4]octane Core Identifies a Potent Nitrofuran Antitubercular Lead

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Microbiology

Background:

• Tuberculosis (TB) remains a major global health challenge, necessitating the development of new antitubercular agents.
• Existing treatments face challenges with drug resistance and side effects, driving the search for novel therapeutic strategies.

Purpose of the Study:

• To synthesize and evaluate a series of nitrofuran carboxamide derivatives as potential inhibitors of Mycobacterium tuberculosis.
• To explore the structure-activity relationships of these compounds by varying peripheral substituents, including azole groups.

Main Methods:

• Synthesis of twelve nitrofuran carboxamide compounds utilizing a 2,6-diazaspiro[3.4]octane building block.
• In vitro assessment of the inhibitory activity of synthesized compounds against the H37Rv strain of Mycobacterium tuberculosis.
• Determination of minimal inhibitory concentration (MIC) for active compounds.

Main Results:

• Successful synthesis of a small library of twelve diverse nitrofuran carboxamide derivatives.
• Identification of a highly potent antitubercular lead compound.
• The most active compound exhibited a minimal inhibitory concentration (MIC) of 0.016 μg/mL against Mycobacterium tuberculosis H37Rv.

Conclusions:

• The nitrofuran carboxamide scaffold, derived from 2,6-diazaspiro[3.4]octane, is a promising platform for developing new antitubercular drugs.
• The identified lead compound demonstrates significant in vitro efficacy, warranting further investigation for TB treatment.
• Structural modifications, particularly the incorporation of azole substituents, can enhance antitubercular activity.